Establishing surrogate kidney endpoints for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes
<p>Objective: Endpoints currently used in lupus nephritis (LN) clinical trials lack uniformity and questionably reflect long‐term kidney survival. The objective of this investigation was to identify short‐term endpoints that predict long‐term kidney outcomes for use in clinical trials.</p&g...
Κύριοι συγγραφείς: | Mackay, M, Dall’Era, M, Fishbein, J, Kalunian, K, Lesser, M, Guerrero, J, Levy, DM, Silverman, E, Petri, M, Arriens, C, Lewis, EJ, Korbet, SM, Conti, F, Tesar, V, Hruskova, Z, Borba, EF, Bonfa, E, Chan, T, Rathi, M, Gupta, KL, Jha, V, Hasni, S, West, MR, Solomons, N, Houssiau, FA, Diaz, J, Mejia-Vilet, J, Rovin, BH |
---|---|
Μορφή: | Journal article |
Έκδοση: |
Wiley
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS
ανά: Kenneth Kalunian, κ.ά.
Έκδοση: (2024-03-01) -
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
ανά: Inker, LA, κ.ά.
Έκδοση: (2023) -
Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease
ανά: Vonesh, E, κ.ά.
Έκδοση: (2019) -
Rationale for surrogate endpoints and conditional marketing authorization of new therapies for kidney transplantation
ανά: Naesens, M, κ.ά.
Έκδοση: (2022) -
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS
ανά: Kenneth Kalunian, κ.ά.
Έκδοση: (2024-11-01)